Key Decisionmakers Mark Their Presence At Analytica Anacon India & India Lab Expo 2024 In Mumbai

The recent Mumbai edition of analytica Anacon India and India Lab Expo, organised jointly by Messe Muenchen India and the Indian Analytical Instruments Association (IAIA), concluded successfully with satisfied exhibitors and delighted visitors.

Lupin Secures EIR From US FDA For its Aurangabad Manufacturing Facility

Lupin Limited, a leading global pharmaceutical company, has secured the Establishment Inspection Report (EIR) from the US Food and Administration (FDA) for its Aurangabad manufacturing facility. The investigation was led from March 6 to March 15...

Sarvodaya Hospital Redefines Total Knee Replacement Surgery with Augmented Reality

Sarvodaya Hospital, a leading multidisciplinary tertiary care facility in Greater Noida West, witnessed a groundbreaking advancement in orthopedic surgery as a 70-year-old male underwent a transformative Total Knee Replacement (TKR)

Emblaveo Receives EC Approval For Patients with Multidrug-resistant Infections

Pfizer Inc., a biopharmaceutical firm, reported that Emblaveo (aztreonam-avibactam) has received marketing approval from the European Commission (EC) for the treatment of adult patients with pyelonephritis, hospital-acquired pneumonia (HAP)...

Ipsen and Skyhawk Foray Research Collaboration in Neurological Diseases

Ipsen, a worldwide biopharmaceutical organization, announced a worldwide collaboration with Skyhawk Therapeutics, a clinical-stage biopharmaceutical organization, to find and foster novel little particles that tweak RNA for intriguing neurological...

Bristol and Cellares Declares $380 mn Supply Pact To Produce Cell Therapies

In a deal worth up to $380 million in upfront and milestone payments, Bristol Myers Squibb and Cellares, the first Integrated Development and Manufacturing Organization (IDMO) dedicated to clinical and industrial-scale cell therapy manufacturing...

© 2024 India Pharma Outlook. All Rights Reserved.